A detailed history of Charles Schwab Investment Management Inc transactions in Medicinova Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 71,506 shares of MNOV stock, worth $152,307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,506
Previous 134,793 46.95%
Holding current value
$152,307
Previous $194,000 22.68%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.13 - $2.1 $71,514 - $132,902
-63,287 Reduced 46.95%
71,506 $150,000
Q2 2024

Aug 12, 2024

BUY
$1.28 - $1.57 $172,535 - $211,625
134,793 New
134,793 $194,000
Q2 2021

Aug 16, 2021

SELL
$3.76 - $5.14 $352,545 - $481,936
-93,762 Reduced 84.01%
17,843 $76,000
Q1 2021

May 17, 2021

BUY
$4.81 - $8.74 $57,503 - $104,486
11,955 Added 12.0%
111,605 $564,000
Q4 2020

Feb 16, 2021

BUY
$5.03 - $6.31 $1,539 - $1,930
306 Added 0.31%
99,650 $525,000
Q3 2020

Nov 13, 2020

SELL
$4.67 - $11.0 $15,859 - $37,356
-3,396 Reduced 3.31%
99,344 $521,000
Q2 2020

Aug 14, 2020

BUY
$3.06 - $7.06 $10,116 - $23,340
3,306 Added 3.32%
102,740 $557,000
Q4 2019

Feb 07, 2020

BUY
$6.48 - $8.76 $21,558 - $29,144
3,327 Added 3.46%
99,434 $671,000
Q2 2019

Aug 09, 2019

BUY
$8.29 - $13.22 $48,662 - $77,601
5,870 Added 6.51%
96,107 $926,000
Q1 2019

May 14, 2019

BUY
$6.82 - $10.27 $27,293 - $41,100
4,002 Added 4.64%
90,237 $748,000
Q3 2018

Nov 13, 2018

BUY
$7.06 - $12.49 $49,420 - $87,430
7,000 Added 8.83%
86,235 $1.08 Million
Q2 2018

Aug 08, 2018

BUY
$7.96 - $13.23 $83,062 - $138,055
10,435 Added 15.17%
79,235 $631,000
Q1 2018

May 07, 2018

BUY
$6.6 - $13.91 $76,560 - $161,356
11,600 Added 20.28%
68,800 $704,000
Q4 2017

Jan 17, 2018

BUY
$5.89 - $7.21 $63,612 - $77,868
10,800 Added 23.28%
57,200 $371,000
Q3 2017

Nov 13, 2017

BUY
$4.43 - $6.58 $205,552 - $305,312
46,400
46,400 $296,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $104M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.